Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sienco is a private U.S. medical device and in vitro diagnostics company focused on hemostasis monitoring and viscoelastic evaluation of whole blood and platelet function. The company manufactures and distributes the Sonoclot Analyzer family, related test kits, disposables, reagents, and data-analysis software for use in clinical and research settings. Its products are used for point-of-care and laboratory coagulation assessment, including heparin management, platelet function testing, and broader evaluation of clot formation and fibrinolysis. Sienco serves hospitals, operating rooms, intensive care units, coagulation laboratories, and research users, with particular relevance in cardiac surgery, liver transplant, trauma, vascular surgery, and other bleeding-management settings. The company appears to operate as a niche commercial diagnostics/device business rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sienco.